Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2012. Start Trial.
Date Value
November 17, 2026 0.9223
November 16, 2026 0.9223
November 13, 2026 0.9113
November 12, 2026 0.9113
November 11, 2026 0.9434
November 10, 2026 0.9434
November 09, 2026 0.9459
November 06, 2026 0.8881
November 05, 2026 0.9082
November 04, 2026 0.8889
November 03, 2026 0.8889
November 02, 2026 0.8875
October 30, 2026 0.8492
October 29, 2026 0.8492
October 28, 2026 0.8492
October 27, 2026 0.8492
October 26, 2026 0.8492
October 23, 2026 0.8697
October 22, 2026 0.8856
October 21, 2026 0.8856
October 20, 2026 0.8723
October 19, 2026 0.8571
October 16, 2026 0.8728
October 15, 2026 0.8728
October 14, 2026 0.8769
Date Value
October 13, 2026 0.895
October 12, 2026 0.895
October 09, 2026 0.915
October 08, 2026 0.9637
October 07, 2026 0.9637
October 06, 2026 0.9785
October 05, 2026 1.027
October 02, 2026 1.027
October 01, 2026 0.978
September 30, 2026 1.121
September 29, 2026 1.065
September 28, 2026 1.065
September 25, 2026 1.065
September 24, 2026 1.065
September 23, 2026 1.093
September 22, 2026 1.093
September 21, 2026 1.090
September 18, 2026 1.090
September 17, 2026 1.090
September 16, 2026 1.090
September 15, 2026 1.090
September 14, 2026 1.090
September 11, 2026 1.176
September 10, 2026 1.176
September 09, 2026 1.176

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Genmab A/S 4.950
Ascendis Pharma A/S 10.40
Bavarian Nordic A/S 1.297
Evaxion AS 2.240
ACADIA Pharmaceuticals, Inc. 2.221

Price to Book Value Related Metrics